Endoxifen (E-isomer)
CAS No. 114828-90-9
Endoxifen (E-isomer)( E-Endoxifen | Endoxifen E-isomer )
Catalog No. M26199 CAS No. 114828-90-9
Endoxifen E-isomer is the E-isomer of (Z)-Endoxifen. Endoxifen E-isomer has antiestrogenic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 90 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 145 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 458 | In Stock |
|
| 100MG | 719 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEndoxifen (E-isomer)
-
NoteResearch use only, not for human use.
-
Brief DescriptionEndoxifen E-isomer is the E-isomer of (Z)-Endoxifen. Endoxifen E-isomer has antiestrogenic effects.
-
DescriptionEndoxifen E-isomer is the E-isomer of (Z)-Endoxifen. Endoxifen E-isomer has antiestrogenic effects.(In Vitro):Endoxifen exists as the potently anti-estrogenic (Z)-isomer and the lesser-known (E)-isomer. (E)-Endoxifen is identified as the primary degradant. The (E)-isomer is an impurity in (Z)-Endoxifen drug substance and increases under certain storage conditions.
-
In VitroEndoxifen E-isomer (1-1000 nM; 12 h) inhibits PGR gene expression in E2-induced MCF-7 cells.
-
In Vivo——
-
SynonymsE-Endoxifen | Endoxifen E-isomer
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114828-90-9
-
Formula Weight373.49
-
Molecular FormulaC25H27NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (133.87 mM)
-
SMILESOC1=CC=C(/C(C2=CC=C(OCCNC)C=C2)=C(C3=CC=CC=C3)/CC)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs:An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
H3B-5942
H3B-5942 is an orally available, selective estrogen receptor covalent antagonist (SERCA), demonstrates potent ERαantagonist activity in vitro and in vivo.
-
GDC-0927 R-form
GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD).
-
Iriflophenone
Iriflophenone?stimulates cells proliferation in??MCF-7 and T-47D human breast cancer.
Cart
sales@molnova.com